Pharmaceutical Lobbying and Drug-Pricing Policy
PhRMA's reported lobbying and Pfizer's PAC giving during the Medicare negotiation debate
The pharmaceutical industry lobbied against Medicare drug-price negotiation before and after the Inflation Reduction Act of 2022. PhRMA alone reports $141.3M in LDA lobbying across the 505 filings tracked here (whole-filing totals, all issues). Follow the pipeline from the trade group to Pfizer and its corporate PAC's giving to members of Congress.
Dollar figures are reconciled to the records held in this database. Each one says what it measures. The trail shows who gave, who spent for or against whom, and what was enacted, with dates. It does not establish that one caused another.
PhRMA reports $141.3M in lobbying across 505 filings
LDA lobbying, whole-filing totals, all issues, 505 filings tracked here
The Pharmaceutical Research and Manufacturers of America is the drug industry's trade group. The 505 LDA filings tracked here report $141.3M in lobbying spend. LDA reports cover every issue a filer lobbied on in the quarter, so this is PhRMA's total reported lobbying in these filings, not spending on drug pricing alone.
The pharmaceutical industry's trade association, representing the research-based drug makers. Its LDA filings, PAC and state-filing contributor rows are consolidated here.
Pfizer, a PhRMA member, gives through a separate corporate PAC
Pfizer is one of the largest PhRMA members and a maker of drugs selected for Medicare negotiation. Corporate money reaches candidates through a separate FEC committee, Pfizer Inc. PAC, funded by employee contributions; the next stop shows that committee's tracked giving. This database does not record which members' positions on drug pricing the PAC's giving tracked.
One of the world's largest pharmaceutical companies ($58.5 billion revenue in 2023). Maker of the COVID-19 vaccine (Comirnaty), Paxlovid, and extensive oncology portfolio.
Pfizer Inc. PAC: $1.85M in tracked direct giving since 2015
tracked direct giving, 637 contributions, 2015-02-26 to 2026-06-30
Pfizer Inc. PAC's 637 tracked contributions total $1.85M between February 2015 and June 2026. Its profile lists the recipients, including members of the House Energy and Commerce and Senate Finance Committees, the panels with jurisdiction over drug-pricing legislation.
Pfizer employee political action committee. One of the largest pharma PACs, contributing to members of health and commerce committees.